VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 715 filers reported holding VANECK VECTORS ETF TR in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,523,860 | -7.6% | 93,787 | +3.4% | 0.10% | -6.7% |
| Q2 2023 | $2,732,417 | +6.5% | 90,746 | +14.4% | 0.10% | 0.0% |
| Q1 2023 | $2,566,518 | +74.2% | 79,334 | +54.3% | 0.10% | +41.9% |
| Q4 2022 | $1,473,480 | +601.7% | 51,412 | +489.9% | 0.07% | +572.7% |
| Q3 2022 | $210,000 | -0.9% | 8,716 | +12.6% | 0.01% | 0.0% |
| Q2 2022 | $212,000 | -38.9% | 7,741 | -14.3% | 0.01% | -26.7% |
| Q1 2022 | $347,000 | +66.0% | 9,034 | +39.0% | 0.02% | +66.7% |
| Q4 2021 | $209,000 | -17.7% | 6,500 | -13.3% | 0.01% | -30.8% |
| Q2 2021 | $254,000 | +23.9% | 7,498 | +19.3% | 0.01% | +8.3% |
| Q1 2021 | $205,000 | -60.1% | 6,287 | -52.1% | 0.01% | -93.9% |
| Q3 2020 | $514,000 | -51.9% | 13,119 | -55.0% | 0.20% | +106.3% |
| Q2 2020 | $1,069,000 | +123.6% | 29,155 | +40.5% | 0.10% | +86.3% |
| Q1 2020 | $478,000 | -13.4% | 20,750 | +10.1% | 0.05% | +18.6% |
| Q4 2019 | $552,000 | -42.7% | 18,855 | -47.7% | 0.04% | -56.6% |
| Q3 2019 | $963,000 | +70.7% | 36,041 | +62.5% | 0.10% | +57.1% |
| Q2 2019 | $564,000 | -7.2% | 22,178 | -17.3% | 0.06% | -68.5% |
| Q1 2019 | $608,000 | +162.1% | 26,816 | +145.6% | 0.20% | +325.5% |
| Q4 2018 | $232,000 | -26.1% | 10,919 | -21.4% | 0.05% | +9.3% |
| Q2 2018 | $314,000 | -22.1% | 13,894 | -24.5% | 0.04% | -23.2% |
| Q1 2018 | $403,000 | +27.1% | 18,394 | +37.2% | 0.06% | +16.7% |
| Q4 2017 | $317,000 | -51.3% | 13,410 | -51.8% | 0.05% | -51.5% |
| Q3 2017 | $651,000 | +133.3% | 27,835 | +117.7% | 0.10% | +120.0% |
| Q2 2017 | $279,000 | -29.7% | 12,785 | -25.2% | 0.04% | -37.5% |
| Q1 2017 | $397,000 | +0.8% | 17,099 | -2.8% | 0.07% | -6.5% |
| Q4 2016 | $394,000 | +45.4% | 17,599 | +71.4% | 0.08% | +42.6% |
| Q3 2016 | $271,000 | -52.7% | 10,265 | -50.3% | 0.05% | -54.2% |
| Q2 2016 | $573,000 | – | 20,672 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |